![\"\"](\"https://cms.cmm.se/wp-content/uploads/2026/09/tomas_olsson_sls_pris_2026-251x300.jpg\")
CMM Group Leader Professor Tomas Olsson is awarded the Swedish Society of Medicine’s Jubilee Prize 2026 for his internationally leading research on multiple sclerosis (MS). His research has contributed groundbreaking insights into the origins of the disease and has opened new possibilities for the treatment and prevention of MS.
\n\nThe Swedish Society of Medicine published the following press release:
\nCMM Group Leader Tomas Olsson, Professor of Neurology at the Department of Clinical Neuroscience, Karolinska Institutet, is awarded the Jubileumspriset (Jubilee Prize) for his groundbreaking research on the genetic and immunological mechanisms underlying multiple sclerosis (MS).
\nBy combining genetic, epidemiological, and immunological studies, he has contributed to a deeper understanding of how heredity, environmental factors, lifestyle, and viral infections influence the risk of developing the disease. His research has, among other things, provided new insights into the connection between the Epstein-Barr virus and MS.
\n\n“It is a great pleasure to recognize Tomas Olsson for his significant contributions to MS research. He has impressively combined experimental and clinical research and built an internationally leading research program of great importance both for scientific advancement and for patients with MS,” says Catharina Ihre Lundgren, Chair of the Swedish Society of Medicine.
\n“Receiving this award is a great honor, and I am deeply grateful. The prize confirms that my research has been meaningful and appreciated by colleagues within the Swedish Society of Medicine, and hopefully has also made a difference for people living with diseases of the nervous system,” says Tomas Olsson.
The award will be presented during the Swedish Society of Medicine’s Annual Ceremony on 20 October 2026. The recipient will receive SEK 175,000 and the Swedish Society of Medicine’s Centenary Silver Medal.
\n
CMM Group Leader Professor Tomas Olsson is awarded the Swedish Society of Medicine’s Jubilee Prize 2026 for his internationally leading research on multiple sclerosis (MS). His research has contributed groundbreaking insights into the origins of the disease and has opened new possibilities for the treatment and prevention of MS.
\n\nThe Swedish Society of Medicine published the following press release:
\nCMM Group Leader Tomas Olsson, Professor of Neurology at the Department of Clinical Neuroscience, Karolinska Institutet, is awarded the Jubileumspriset (Jubilee Prize) for his groundbreaking research on the genetic and immunological mechanisms underlying multiple sclerosis (MS).
\nBy combining genetic, epidemiological, and immunological studies, he has contributed to a deeper understanding of how heredity, environmental factors, lifestyle, and viral infections influence the risk of developing the disease. His research has, among other things, provided new insights into the connection between the Epstein-Barr virus and MS.
\n\n“It is a great pleasure to recognize Tomas Olsson for his significant contributions to MS research. He has impressively combined experimental and clinical research and built an internationally leading research program of great importance both for scientific advancement and for patients with MS,” says Catharina Ihre Lundgren, Chair of the Swedish Society of Medicine.
\n“Receiving this award is a great honor, and I am deeply grateful. The prize confirms that my research has been meaningful and appreciated by colleagues within the Swedish Society of Medicine, and hopefully has also made a difference for people living with diseases of the nervous system,” says Tomas Olsson.
The award will be presented during the Swedish Society of Medicine’s Annual Ceremony on 20 October 2026. The recipient will receive SEK 175,000 and the Swedish Society of Medicine’s Centenary Silver Medal.
\n